News•Healthcare Business Models and Strategy
Ro's GLP-1 Gold Rush: How the DTC Disruptor Snagged Ozempic, Wegovy, and Zepbound in a $X Billion Social Media Play
Ro's $XB social media play snags Ozempic, Wegovy, Zepbound. Discover how this DTC disruptor dominates the GLP-1 gold rush.
1/29/2026
